Torrent Pharma : Torrent Pharma, the flagship company of the Torrent Group, boasts a substantial market capitalization exceeding $12 billion USD. With over half a century of dedicated service, Torrent has emerged as a prominent player in the global pharmaceutical landscape. Our expertise shines particularly in therapeutic segments encompassing cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI), and women's healthcare (WHC). Our competitive edge is deeply rooted in state-of-the-art manufacturing facilities that have earned approvals from globally esteemed regulatory authorities such as the US, EU, TGA (Australia), MHRA (UK), TH FDA, and many more. Present in over 50 countries, we have strategically segmented Torrent Pharma's international business across the United States, the United Kingdom, Germany, Europe, Brazil, and emerging markets to foster strategic differentiation.

Torrent Pharma, a pioneer in the introduction of Neurology, Psychiatric and cardiology medications in over 50 countries, is now extending its commitment to Quality and Affordability to the healthcare landscape of Thailand. With our fundamental principle of "1 Product - 1 Globe - 1 Quality," we are dedicated to providing not only medicines but also building stronger relationships with the medical community.

As an organisation we are expanding our business in Vietnam Market, which is in accordance with our plan of consolidating presence in Southeast Asian market. Banking on Torrent’s high-quality products & brand building capabilities, we aim to reach among the top-ranking companies in the country.

At Torrent, every employee is entrusted with challenging, interesting, and motivating assignments that make them think out of the box. Holistic development of our employees is of prime importance for us. We create an encouraging and conducive work environment for the employees that keeps the zeal to perform alive.